4.6 Article

The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease

Journal

ACTA NEUROPATHOLOGICA
Volume 137, Issue 1, Pages 89-102

Publisher

SPRINGER
DOI: 10.1007/s00401-018-1910-3

Keywords

Neurogranin; Alzheimer's disease; Brain tissue; Familial Alzheimer's disease; Mass spectrometry

Funding

  1. Swedish Research Council
  2. European Research Council
  3. Torsten Soderberg Foundation
  4. Swedish Brain Foundation
  5. Knut and Alice Wallenberg Foundation
  6. Frimurarestiftelsen
  7. Stiftelsen for Gamla Tjanarinnor
  8. Foundation for Research on Alzheimer
  9. Swedish Alzheimer Foundation
  10. Swedish State Support for Clinical Research (ALFGBG)
  11. Alzheimer's Research UK
  12. Leonard Wolfson Centre for Experimental Neurology
  13. UK Dementia Research Institute at UCL
  14. Reta Lila Weston Institute for Neurological Studies
  15. Medical Research Council

Ask authors/readers for more resources

Synaptic degeneration and neuronal loss are early events in Alzheimer's disease (AD), occurring long before symptom onset, thus making synaptic biomarkers relevant for enabling early diagnosis. The postsynaptic protein neurogranin (Ng) is a cerebrospinal fluid (CSF) biomarker for AD, also in the prodromal phase. Here we tested the hypothesis that during AD neurodegeneration, processing of full-length Ng into endogenous peptides in the brain is increased. We characterized Ng in post-mortem brain tissue and investigated the levels of endogenous Ng peptides in relation to full-length protein in brain tissue of patients with sporadic (sAD) and familial Alzheimer's disease (fAD), healthy controls and individuals who were cognitively unaffected but amyloid-positive (CU-AP) in two different brain regions. Brain tissue from parietal cortex [sAD (n = 10) and age-matched controls (n = 10)] and temporal cortex [sAD (n=9), fAD (n=10), CU-AP (n=13) and controls (n=9)] were included and all the samples were analyzed by three different methods. Using high-resolution mass spectrometry, 39 endogenous Ng peptides were identified while full-length Ng was found to be modified including disulfide bridges or glutathione. In sAD parietal cortex, the ratio of peptide-to-total full-length Ng was significantly increased for eight endogenous Ng peptides compared to controls. In the temporal cortex, several of the peptide-to-total full-length Ng ratios were increased in both sAD and fAD cases compared to controls and CU-AP. This finding was confirmed by western blot, which mainly detects full-length Ng, and enzyme-linked immunosorbent assay, most likely detecting a mix of peptides and full-length Ng. In addition, Ng was significantly associated with the degree of amyloid and tau pathology. These results suggest that processing of Ng into peptides is increased in AD brain tissue, which may reflect the ongoing synaptic degeneration, and which is also mirrored as increased levels of Ng peptides in CSF.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available